Patient engagement reduces readmission from chronic conditions

West Virginia's Charleston Area Medical Center (CAMC), after its implementation of the patient engagement and education system, has reduced readmission of patients with chronic conditions such as congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD).

The SmarTigr system uses smart TVs, software platforms, mobile applications and interactive videos to educate patients and increase their engagement in their own care. The system also goes one step further with condition-specific tools, activity reports and patient monitoring.  

“Many patients are visual learners and can better retain information from videos than from reading patient handouts. Videos along with corresponding quizzes through the television in their room stimulate conversation and facilitate learning for the whole family,” said Don Lilly, MD. a cardiologist and associate chief medical officer at CAMC. “When patients involve their own family members in the process, they have more support and a greater chance of compliance once they go home. That helps to keep them from coming back to the hospital.”

With the addition of SmarTigr and its tools, CAMC has reduced readmission of CHF by 22 percent and COPD by 30 percent. By offering the engagement system, patients were able to educate themselves through many different facets to take charge of their care. The improved coordination of care between physicians and patients improves results while also improving clinical workflows.

“Seeing this positive trend in reducing readmissions and improving satisfaction has led other units and departments to look at the patient engagement system as a way to improve delivery of education and better prepare patients for taking care of themselves after discharge,” said Beverly Thornton, RN, CAMC education director. 

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.